Cargando…
Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants
Due to a lack of published pharmacokinetic (PK) and/or pharmacodynamic (PD) data, informed physician and patient decision-making surrounding appropriate dosing of cannabis for medical purposes is limited. This Phase 1, multiple-dose study evaluated the safety, tolerability, PK and PD of Spectrum Red...
Autores principales: | Peters, Erica N, Mosesova, Irina, MacNair, Laura, Vandrey, Ryan, Land, M Hunter, Ware, Mark A, Turcotte, Cynthia, Bonn-Miller, Marcel O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122503/ https://www.ncbi.nlm.nih.gov/pubmed/33848338 http://dx.doi.org/10.1093/jat/bkab035 |
Ejemplares similares
-
Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy Participants
por: Peters, Erica N, et al.
Publicado: (2021) -
Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ(9)-tetrahydrocannabinol: a pilot study
por: Peters, Erica N., et al.
Publicado: (2021) -
Pharmacokinetic studies of solubilized estradiol given vaginally in a novel softgel capsule
por: Pickar, J. H., et al.
Publicado: (2016) -
Effect of Cannabidiol on the Long-Term Toxicity and Lifespan in the Preclinical Model Caenorhabditis elegans
por: Land, M. Hunter, et al.
Publicado: (2021) -
Physical characteristics and properties of estradiol softgel vaginal inserts
por: Simon, James A., et al.
Publicado: (2019)